...
首页> 外文期刊>Cancer epidemiology >Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.
【24h】

Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.

机译:在法国通过死亡证明记录子宫癌的可靠性以及子宫颈和子宫体死亡的特定年龄比例。

获取原文
获取原文并翻译 | 示例
           

摘要

French uterine cancer recordings in death certificates include 60% of "uterine cancer, Not Otherwise Specified (NOS)"; this hampers the estimation of mortalities from cervix and corpus uteri cancers. The aims of this work were to study the reliability of uterine cancer recordings in death certificates using a case matching with cancer registries and estimate age-specific proportions of deaths from cervix and corpus uteri cancers among all uterine cancer deaths by a statistical approach that uses incidence and survival data. Deaths from uterine cancer between 1989 and 2001 were extracted from the French National database of causes of death and case-to-case matched to women diagnosed with uterine cancer between 1989 and 1997 in 8 cancer registries. Registry data were considered as gold-standard cervix and 995 corpus uteri cancers. In death certificates, 5% and 40% of "true" cervix cancers were respectively coded "corpus" and "uterus, NOS" and 5% and 59% of "true" corpus cancers respectively coded "cervix" and "uterus, NOS". Miscoding cervix cancers was more frequent at advanced ages at death and in deaths at home or in small urban areas. Miscoding corpus cancers was more frequent in deaths at home or in small urban areas. From the statistical method, the estimated proportion of deaths from cervix cancer among all uterine cancer deaths was higher than 95% in women aged 30-40 years old but declined to 35% in women older than 70 years. The study clarifies the reason for poor encoding of uterus cancer mortality and refines the estimation of mortalities from cervix and corpus uteri cancers allowing future studies on the efficacy of cervical cancer screening.
机译:法国在死亡证明书中记录的子宫癌包括60%的“未另外指明的子宫癌”(NOS);这不利于估计子宫颈癌和子宫体癌的死亡率。这项工作的目的是使用与癌症登记机构相匹配的病例研究死亡证书中子宫癌记录的可靠性,并通过使用发病率的统计方法估算所有子宫癌死亡中特定年龄段子宫颈癌和子宫体癌死亡的比例。和生存数据。 1989年至2001年之间的子宫癌死亡病例是从法国国家死亡原因数据库中提取的,并与1989年至1997年间在8个癌症登记处被诊断出患有子宫癌的妇女进行逐案匹配。登记数据被认为是金标准子宫颈癌和995例子宫体癌。在死亡证明中,分别有5%和40%的“真实”子宫颈癌编码为“主体”和“子宫,NOS”,分别有5%和59%的“真实”子宫颈癌分别标记为“子宫颈”和“子宫,NOS” 。子宫颈癌的错误编码在高龄死亡以及在家庭或小城市地区的死亡中更为常见。在家庭或小城市地区死亡中,语料库癌症误码率更高。根据统计方法,在所有30-40岁的女性中,宫颈癌死亡的比例在所有子宫癌死亡中所占的比例高于95%,但在70岁以上的女性中下降至35%。这项研究阐明了子宫癌死亡率编码不良的原因,并完善了宫颈癌和体子宫癌死亡率的估计,从而可以进一步研究宫颈癌筛查的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号